Study on the incidence and related risk factors for impulsive control disorders in Parkinson's disease

doi:10.3969/j.issn.1672-6731.2021.11.010

Abstract

Abstract:

Objective To investigate the incidence and risk factors for impulsive control disorders (ICDs) in Parkinson's disease (PD). Methods A total of 201 patients with PD were included from May 2016 to September 2017. ICDs were assessed by Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP). Mentation, behavior and mood, activities of daily living, motor function, and complications for therapy were assessed by Unified Parkinson's Disease Rating Scale (UPDRS). Disease severity was assessed by Hoehn-Yahr staging, and depression was assessed by Geriatric Depression Scale (GDS). Univariate and multivariate forward Logistic regression analyses were used to analyze the risk factors for PD patients with ICDs. Results Among 201 PD patients, 41 patients (20.40%) were diagnosed with ICDs, including 17 cases of compulsive medicine use (8.46%), 15 cases of compulsive eating (7.46%), 13 cases of punding (6.46%), 8 cases of compulsive shopping (3.98%), 3 cases of pathological gambing (1.49%) and one case of hypersexuality (0.49%). Logistic regression analysis showed that the longer treatment duration (OR=1.237, 95%CI:1.038-1.474; P=0.018), severe complications for therapy (high UPDRS Ⅳ score; OR=1.389, 95%CI:1.077-1.790, P=0.011), depression (OR=2.417, 95%CI:0.174-0.984; P=0.046) were the risk factors for PD patients with ICDs. Conclusions The incidence of ICDs in PD is high, which is affected by many factors. The risk of ICDs can be evaluated by the QUIP scale to guide medication.

Key words: Parkinson disease, Disruptive, impulse control, and conduct disorders, Depression, Risk factors, Logistic models

摘要：

目的总结帕金森病患者冲动控制障碍发生率并筛查其相关危险因素。方法纳入2016年5月至2017年9月中国医科大学附属第一医院收治的201例原发性帕金森病患者，采用冲动控制障碍问卷（QUIP）评估冲动控制障碍；统一帕金森病评价量表第一至四部分（UPDRSⅠ~Ⅳ）分别评估精神、行为和情绪，日常活动，运动功能，治疗相关并发症；Hoehn-Yahr分期评估疾病严重程度；老年抑郁量表（GDS）评估抑郁症状。单因素和多因素前进法Logistic回归分析筛查帕金森病冲动控制障碍相关危险因素。结果共201例帕金森病患者，经QUIP量表筛查出41例冲动控制障碍患者，冲动控制障碍发生率为20.40%，主要表现为强迫性服药占8.46%（17/201）、强迫性饮食占7.46%（15/201）、刻板行为占6.46%（13/201）、强迫性购物占3.98%（8/201）、病理性赌博占1.49%（3/201）、性欲亢进占0.49%（1/201）。Logistic回归分析显示，服药时间长（OR=1.237，95% CI：1.038~1.474；P=0.018）、UPDRSⅣ评分高（OR=1.389，95% CI：1.077~1.790；P=0.011）、抑郁（OR=2.417，95% CI：0.174~0.984；P=0.046）是帕金森病冲动控制障碍的危险因素。结论帕金森病冲动控制障碍发生率较高，服药时间长、治疗相关并发症严重、抑郁是其危险因素，临床可以根据QUIP量表评估冲动控制障碍风险以指导临床用药。

关键词: 帕金森病, 破坏性、冲动控制和行为障碍, 抑郁, 危险因素, Logistic模型

XIE Xin, LUO Xiao-guang, CHEN Rong-jie. Study on the incidence and related risk factors for impulsive control disorders in Parkinson's disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2021, 21(11): 982-987.

谢欣, 罗晓光, 陈荣杰. 帕金森病冲动控制障碍发生率及相关影响因素分析[J]. 中国现代神经疾病杂志, 2021, 21(11): 982-987.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2021.11.010

https://journal11.magtechjournal.com/cjcnn/EN/Y2021/V21/I11/982

References

[1] Gan C, Wang L, Ji M, Ma K, Sun H, Zhang K, Yuan Y. Abnormal interhemispheric resting state functional connectivity in Parkinson's disease patients with impulse control disorders[J]. NPJ Parkinsons Dis, 2021, 7:60.
[2] Weintraub D, Mamikonyan E. Impulse control disorders in Parkinson's disease[J]. Am J Psychiatry, 2019, 176:5-11.
[3] Kelly MJ, Baig F, Hu MT, Okai D. Spectrum of impulse control behaviours in Parkinson's disease:pathophysiology and management[J]. J Neurol Neurosurg Psychiatry, 2020, 91:703-711.
[4] Marques A, Roquet D, Matar E, Taylor NL, Pereira B, O'Callaghan C, Lewis SJG. Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders[J]. J Neurol, 2021, 268:3371-3380.
[5] Picillo M, Phokaewvarangkul O, Poon YY, McIntyre CC, Beylergil SB, Munhoz RP, Kalia SK, Hodaie M, Lozano AM, Fasano A. Levodopa versus dopamine agonist after subthalamic stimulation in Parkinson's disease[J]. Mov Disord, 2021, 36:672-680.
[6] Eisinger RS, Ramirez-Zamora A, Carbunaru S, Ptak B, Peng-Chen Z, Okun MS, Gunduz A. Medications, deep brain stimulation, and other factors influencing impulse control disorders in Parkinson's disease[J]. Front Neurol, 2019, 10:86.
[7] Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 1988, 51:745-752.
[8] Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease[J]. Mov Disord, 2010, 25:2649-2653.
[9] Erga AH, Alves G, Tysnes OB, Pedersen KF. Impulsive and compulsive behaviors in Parkinson's disease:impact on quality of and satisfaction with life, and caregiver burden[J]. Parkinsonism Relat Disord, 2020, 78:27-30.
[10] Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, Jeon BS. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease[J]. Parkinsonism Relat Disord, 2010, 16:202-207.
[11] Poletti M, Logi C, Lucetti C, Del Dotto P, Baldacci F, Vergallo A, Ulivi M, Del Sarto S, Rossi G, Ceravolo R, Bonuccelli U. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease:association with dopaminergic drugs[J]. J Clin Psychopharmacol, 2013, 33:691-694.
[12] Lim SY, Tan ZK, Ngam PI, Lor TL, Mohamed H, Schee JP, Tan AK, Goh JY, Ooi E, Soh PC. Impulsive-compulsive behaviors are common in Asian Parkinson's disease patients:assessment using the QUIP[J]. Parkinsonism Relat Disord, 2011, 17:761-764.
[13] Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V. Impulse control disorders and depression in Finnish patients with Parkinson's disease[J]. Parkinsonism Relat Disord, 2012, 18:155-160.
[14] Erga AH, Alves G, Tysnes OB, Pedersen KF. Evolution of impulsive-compulsive behaviors and cognition in Parkinson's disease[J]. J Neurol, 2020, 267:259-266.
[15] Ihle J, Artaud F, Bekadar S, Mangone G, Sambin S, Mariani LL, Bertrand H, Rascol O, Durif F, Derkinderen P, Scherzer C, Elbaz A, Corvol JC; DIGPD study group, Steering committee, Statistical analyses, Principal investigators for sites, Co-investigators (alphabetical order), Neuropsychologists, Genetic core, Sponsor activities and clinical research assistants. Parkinson's disease polygenic risk score is not associated with impulse control disorders:a longitudinal study[J]. Parkinsonism Relat Disord, 2020, 75:30-33.
[16] Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel -Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A; DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease[J]. Neurology, 2018, 91:e189-201.
[17] Zhang JF, Wang XX, Feng Y, Fekete R, Jankovic J, Wu YC. Impulse control disorders in Parkinson's disease:epidemiology, pathogenesis and therapeutic strategies[J]. Front Psychiatry, 2021, 12:635494.
[18] Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE. Impulse control disorders in Parkinson disease:a cross-sectional study of 3090 patients[J]. Arch Neurol, 2010, 67:589-595.
[19] Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E. Chronic dopaminergic stimulation in Parkinson's disease:from dyskinesias to impulse control disorders[J]. Lancet Neurol, 2009, 8:1140-1149.
[20] Ambermoon P, Carter A, Hall WD, Dissanayaka NN, O'Sullivan JD. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy:evidence and implications for the addictions field[J]. Addiction, 2011, 106:283-293.
[21] Weintraub D, Sohr M, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE. Amantadine use associated with impulse control disorders in Parkinson disease in cross -sectional study[J]. Ann Neurol, 2010, 68:963-968.
[22] Dhillon R, Bastiampillai T, Cao CZ, Eckert TG, Tibrewal P. Aripiprazole and impulse-control disorders:a recent FDA warning and a case report[J]. Prim Care Companion CNS Disord, 2017, 19(1).
[23] Marín-Lahoz J, Sampedro F, Martinez -Horta S, Pagonabarraga J, Kulisevsky J. Depression as a risk factor for impulse control disorders in Parkinson disease[J]. Ann Neurol, 2019, 86:762-769.

Please choose a citation manager

Content to export